Related Experiment Video
Updated: Oct 4, 2025

05:33
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
1.8K
Diversifying preclinical research tools: expanding patient-derived models to address cancer health disparities
Nicole B Halmai1, Luis G Carvajal-Carmona2
1Genome Center, University of California, Davis. Davis, CA 95616, USA.
Trends in Cancer
|February 7, 2022
Abstract:
Cancer health disparities define a critical healthcare issue for racial/ethnic minorities in the USA. Key findings have led to cancer treatment improvements tailored to minority patients, but such successes have been rare. Here, we highlight how the use of patient-derived xenograft (PDX) and organoid models could resolve current blocks toward precision cancer health equity.

